Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
- Emmanuel Musisi
- , Adam J. Wyness
- , Sahar Eldirdiri
- , Evelin Dombay
- , Bariki A. Mtafya
- , Nyanda E. Ntinginya
- , Norbert Heinrich
- , Gibson S. Kibiki
- , Michael Hoelscher
- , Martin Boeree
- , Rob Aarnoutse
- , Stephen H. Gillespie
- , Wilber Sabiiti*
- , PanACEA Consortium
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review